Lausanne, OH, United States of America

Horacio Comas

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Horacio Comas. Retrieved from https://idiyas.com/inventor/horacio-comas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Horacio Comas: Innovator in Pharmaceutical Chemistry

Introduction

Horacio Comas is a notable inventor based in Lausanne, OH (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Horacio Comas holds 1 patent for his work on Triazolopyrazine derivatives. These compounds are characterized by the formula I, where R and R have specific meanings as indicated in the claims. His invention serves as an inhibitor of Syk and can be employed for the treatment of rheumatoid arthritis.

Career Highlights

Comas is currently associated with Merck Patent GmbH, a leading company in the pharmaceutical industry. His work focuses on innovative solutions that address complex health issues, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Horacio has collaborated with esteemed colleagues, including Lars Thore Burgdorf and Melanie Schultz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Horacio Comas exemplifies the spirit of innovation in the pharmaceutical sector, with his contributions paving the way for new treatments in healthcare. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…